Lagura, Wilhelmina B.
HRN: 27-82-08 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2025
CEFTRIAXONE 1G (VIAL)
09/19/2025
09/26/2025
IV
2g
OD
CAP MR
Checking Initial Appropriateness
09/19/2025
AZITHROMYCIN 500MG TABLET (TAB)
09/19/2025
09/26/2025
PO
500
OD
CAP MR
Checking Initial Appropriateness
09/24/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/24/2025
10/01/2025
IV
2.25mg
Q6
CAP Non Resolve
Checking Initial Appropriateness